Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $18.51 million. The enterprise value is $10.83 million.
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 2.71 million shares outstanding. The number of shares has increased by 86.67% in one year.
| Current Share Class | 2.71M |
| Shares Outstanding | 2.71M |
| Shares Change (YoY) | +86.67% |
| Shares Change (QoQ) | +115.92% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.77 |
| P/TBV Ratio | 2.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.80 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -488.73 |
Financial Efficiency
Return on equity (ROE) is -127.76% and return on invested capital (ROIC) is -82.28%.
| Return on Equity (ROE) | -127.76% |
| Return on Assets (ROA) | -58.31% |
| Return on Invested Capital (ROIC) | -82.28% |
| Return on Capital Employed (ROCE) | -154.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$835,454 |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.80% in the last 52 weeks. The beta is 0.85, so QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -76.80% |
| 50-Day Moving Average | 6.48 |
| 200-Day Moving Average | 5.57 |
| Relative Strength Index (RSI) | 53.04 |
| Average Volume (20 Days) | 920,583 |
Short Selling Information
The latest short interest is 354,435, so 13.10% of the outstanding shares have been sold short.
| Short Interest | 354,435 |
| Short Previous Month | 47,433 |
| Short % of Shares Out | 13.10% |
| Short % of Float | 15.08% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.14M |
| Pretax Income | n/a |
| Net Income | -14.20M |
| EBITDA | -15.65M |
| EBIT | -16.14M |
| Earnings Per Share (EPS) | -$12.49 |
Full Income StatementBalance Sheet
The company has $7.20 million in cash and $824,922 in debt, giving a net cash position of $6.37 million or $2.35 per share.
| Cash & Cash Equivalents | 7.20M |
| Total Debt | 824,922 |
| Net Cash | 6.37M |
| Net Cash Per Share | $2.35 |
| Equity (Book Value) | 10.44M |
| Book Value Per Share | 4.99 |
| Working Capital | 5.37M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.88M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.88M |
| FCF Per Share | -$2.54 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |